Generated by GPT-5-mini| A*STAR | |
|---|---|
![]() | |
| Name | A*STAR |
| Type | statutory board |
| Founded | 1991 |
| Headquarters | Singapore |
| Region served | Singapore, Southeast Asia, global |
| Leader title | Chief Executive |
A*STAR Agency for Science, Technology and Research is a Singaporean statutory board that coordinates scientific research, drives technology translation, and supports innovation across biomedical sciences and physical sciences. It operates research institutes, translational centers, and talent programs, partnering with universities, multinational corporations, and startups to advance applied research and economic development. The agency engages with national agencies, international organizations, and industry consortia to deploy technologies in healthcare, manufacturing, and urban solutions.
Founded in 1991 under the auspices of Singaporean policy reforms, the agency evolved through strategic initiatives linking national laboratories, university collaborations, and corporate research laboratories such as GlaxoSmithKline, Siemens, IBM, Boehringer Ingelheim, and Pfizer. Its trajectory intersected with regional integration efforts exemplified by the Association of Southeast Asian Nations science dialogues and partnerships with institutions like Massachusetts Institute of Technology, Stanford University, Imperial College London, University of Cambridge, and National University of Singapore. Major reorganizations mirrored international trends in translational research seen at National Institutes of Health, European Molecular Biology Laboratory, and Fraunhofer Society, while funding strategies resembled models from Bill & Melinda Gates Foundation programmatic investments and Wellcome Trust initiatives.
The agency reports to Singaporean ministers and interfaces with statutory entities similar to Singapore Economic Development Board and Enterprise Singapore. Its governance structure incorporates boards and advisory panels with members from multinational corporations like Roche, Novartis, Microsoft Corporation, and academic leaders from Harvard University, Yale University, University of Oxford, and Peking University. Executive leadership collaborates with regulatory bodies including Health Sciences Authority (Singapore), standards organizations such as International Organization for Standardization, and finance ministries modeled after frameworks used by European Investment Bank and Asian Development Bank.
The agency oversees a network of institutes and translational centers analogous to entities like Johns Hopkins Bloomberg School of Public Health, Broad Institute, Max Planck Institutes, and SRI International. Notable institutes include those focused on molecular biology, chemical sciences, materials research, and computational engineering, collaborating with hospitals such as Singapore General Hospital and research hospitals like Mayo Clinic, Cleveland Clinic, and Karolinska Institutet. Centers for advanced manufacturing work with consortia including Manufacturing USA and standards labs similar to National Physical Laboratory (UK).
Research programs span biomedical sciences, physical sciences, information and communications technologies, and urban solutions, reflecting thematic overlaps with initiatives like Human Genome Project, Human Cell Atlas, Graphene Flagship, and International Thermonuclear Experimental Reactor. Programs target precision medicine, drug discovery, advanced materials, photonics, semiconductors, robotics, and artificial intelligence research linked to efforts at DeepMind, OpenAI, NVIDIA, Intel, and ARM Holdings. Public health and translational initiatives intersect with projects from World Health Organization and clinical trial networks such as ClinicalTrials.gov-linked consortia.
The agency engages in technology transfer, licensing, and spin-out programs comparable to practices at Stanford Technology Ventures Program and incubators like Y Combinator, Techstars, and Block71. Partnerships with multinational firms, small and medium enterprises, and venture capital firms including Sequoia Capital, Temasek Holdings, SoftBank Vision Fund, and Vertex Ventures facilitate commercialization. Collaborative agreements mirror models used by Bell Labs, AT&T Labs, and Microsoft Research, while intellectual property frameworks align with standards used by World Intellectual Property Organization.
Talent programs include scholarships, postdoctoral fellowships, industry attachment schemes, and graduate research programs that parallel initiatives at Rhodes Scholarships, Fulbright Program, Marie Skłodowska-Curie Actions, and university graduate schools like University of California, Berkeley Graduate Division. Outreach and public engagement collaborate with museums and science centers such as Science Museum London, Smithsonian Institution, Singapore Science Centre, and secondary school outreach modeled on FIRST Robotics Competition and International Mathematical Olympiad training camps.
The agency has contributed to translational outcomes in therapeutics, diagnostics, advanced manufacturing, and digital innovation, leading to collaborations and spin-offs recognized alongside achievements from Moderna, Gilead Sciences, Illumina, CRISPR Therapeutics, and Genentech. Awards and recognitions for affiliated researchers include honors similar to Lasker Award, Nobel Prize, Breakthrough Prize, and fellowship elections to academies such as Royal Society, National Academy of Sciences, and Academia Sinica. Collaborative projects have influenced regional innovation ecosystems connected to Singapore Science Park, Biopolis, JTC Corporation developments, and global research networks including Global Research Council.
Category:Research institutes in Singapore